NORD's Living Rare Study Aims to Transform Rare Disease Understanding
This initiative will enhance policy and resource allocation
Today, the National Organization for Rare Disorders (NORD) unveiled the Living Rare Study, a revolutionary initiative aimed at understanding the full range of challenges faced by individuals living with rare diseases. As the first extensive study of its kind, it seeks to shed light on the unique hurdles encountered by patients and their caregivers, helping to improve access to healthcare and vital resources.
"Rare diseases impact over 30 million Americans, representing a significant public health concern. However, the absence of comprehensive data has obscured their impact," stated Pamela Gavin, the CEO of NORD. The Living Rare Study is set to remedy this situation by collecting firsthand experiences from those affected, thus providing essential insights for advocating improvements in healthcare policy.
This study, developed with feedback from patients and caregivers, will delve into various facets of living with a rare disease, such as healthcare accessibility, emotional challenges, and financial strains faced by families. By exploring important factors like geography and access to treatment, it aims to illuminate how these variables can influence health outcomes for rare disease patients.
"For the first time, we will gather extensive data not just on medical difficulties but also on the wider social and economic implications of rare diseases," remarked Edward Neilan, M.D., Ph.D., Chief Medical and Scientific Officer of NORD. He emphasized that such insights are critical for improving the management of rare diseases and promoting equitable health care access.
NORD intends to leverage the data gleaned from this study to highlight pressing issues, shape future initiatives, and educate both the public and policymakers about the existing challenges faced by the rare disease community. They plan to regularly publish reports that analyze these factors and inform resource allocation at both local and national levels.
The Living Rare Study welcomes participation from anyone diagnosed with a rare disease, as well as their caregivers, who can offer a critical perspective on the research. The survey is designed to be user-friendly and adaptable, allowing individuals to participate at their convenience and update their insights annually. Participants will have the opportunity to compare their responses with those of others, making the findings even more impactful. All data will be securely stored on NORD's IAMRARE platform, which adheres to HIPAA standards, ensuring participant confidentiality.
“Living with a rare disease creates interconnected challenges that affect all aspects of life, including finances and emotional well-being,” commented Gavin. “By increasing participation in the study, we can gather more powerful data to advocate for changes that will benefit the rare disease community significantly.”
Learn more about the Living Rare Study and how to get involved by visiting livingrarestudy.org.
About the National Organization for Rare Disorders (NORD)
With over 40 years of dedication to advancing care and treatment for individuals with rare diseases, the National Organization for Rare Disorders (NORD) stands as a leading voice for the approximately 30 million Americans navigating these health challenges. Operating as an independent nonprofit, NORD champions individuals with rare diseases and the groups that support them. Partnering with over 340 patient organizations, their mission is to improve health outcomes by driving advancements in care, research, and policy.
Frequently Asked Questions
What is the Living Rare Study?
The Living Rare Study is a comprehensive research initiative by NORD aimed at gathering data on the challenges faced by individuals living with rare diseases.
Who can participate in the Living Rare Study?
Anyone diagnosed with a rare disease, as well as their caregivers, are encouraged to participate in the study.
How will the findings of the study be used?
NORD will use the findings to inform advocacy efforts, shape programs, and educate the public and lawmakers on the challenges of living with rare diseases.
What type of data will be collected?
The study will collect data on medical challenges, healthcare access, emotional well-being, and financial burdens associated with living with a rare disease.
How does NORD ensure participant privacy?
All data collected will be securely stored on NORD's IAMRARE platform, which is fully compliant with HIPAA regulations to protect participant privacy.
